EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $40,000 | 0.0% | 803 | -89.4% | 0.00% | 0.0% |
Q4 2019 | $40,000 | +300.0% | 7,600 | +3700.0% | 0.00% | +100.0% |
Q1 2019 | $10,000 | +25.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -87.3% | 200 | -98.9% | 0.00% | -75.0% |
Q3 2018 | $63,000 | -63.6% | 18,100 | -42.4% | 0.00% | -71.4% |
Q2 2018 | $173,000 | +652.2% | 31,400 | +368.7% | 0.01% | +600.0% |
Q1 2018 | $23,000 | +76.9% | 6,700 | +4.7% | 0.00% | – |
Q4 2017 | $13,000 | -95.2% | 6,400 | -61.6% | 0.00% | -100.0% |
Q3 2017 | $269,000 | +20.1% | 16,661 | -8.4% | 0.01% | +25.0% |
Q2 2017 | $224,000 | +121.8% | 18,182 | +5.7% | 0.01% | +100.0% |
Q1 2017 | $101,000 | -76.2% | 17,200 | -58.5% | 0.00% | -75.0% |
Q4 2016 | $424,000 | +40.4% | 41,444 | -8.9% | 0.02% | +23.1% |
Q3 2016 | $302,000 | -31.2% | 45,500 | -45.6% | 0.01% | -43.5% |
Q2 2016 | $439,000 | -60.4% | 83,649 | -41.4% | 0.02% | -68.5% |
Q1 2016 | $1,108,000 | +188.5% | 142,702 | +518.6% | 0.07% | +247.6% |
Q4 2015 | $384,000 | – | 23,069 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |